Electrical stimulation in the treatment of bladder dysfunction: technology update

References

• Irwin DE, Milsom I, Hunskaar S, et al. Population-based survey of urinary incontinence, overactive bladder, and other lower urinary tract symptoms in five countries: results of the EPIC study. Eur Urol. 2006;50:1306–1315. doi:10.1016/j.eururo.2006.09.01917049716
   PubMed Web of Science ®Google Scholar
• Agarwal A, Eryuzlu LN, Cartwright R, et al. What is the most bothersome lower urinary tract symptom? Individual- and population-level perspectives for both men and women. Eur Urol. 2014;65:1211–1217. doi:10.1016/j.eururo.2014.01.01924486308
   PubMed Web of Science ®Google Scholar
• Uren AD, Cotterill N, Harding C, et al. The development of the ICIQ-UAB: a patient reported outcome measure for underactive bladder. Neurourol Urodyn. 2019;38(3):996–1004. doi:10.1002/nau.2394730801826
   PubMed Web of Science ®Google Scholar
• Blok BF. Sacral neuromodulation for the treatment of urinary bladder dysfunction: mechanism of action and future directions. Bioelectron Med. 2018;1:85–94. doi:10.2217/bem-2017-0003
   Google Scholar
• Blok BF, Groen J, Bosch JL, et al. Different brain effects during chronic and acute sacral neuromodulation in urge incontinent patients with implanted neurostimulators. BJU Int. 2006;98:1238–1243. doi:10.1111/j.1464-410X.2006.06521.x17034500
   PubMed Web of Science ®Google Scholar
• Sacral neuromodulation Therapy, Implant manual, 2018. Available from: http://professional.medtronic.com/pt/uro/snm/prod/index.htm. Accessed 1216, 2018.
   Google Scholar
• Rittenmeyer H. Sacral nerve neuromodulation (InterStim). Part II: review of programming. Urol Nurs. 2008;28:21–25.18335693
   PubMedGoogle Scholar
• Peeren F, Hoebeke P, Everaert K. Sacral nerve stimulation: interstim therapy. Expert Rev Med Devices. 2005;2:253–258. doi:10.1586/17434440.2.3.25316288588
   PubMed Web of Science ®Google Scholar
• Price DM, Noblett K. Prospective randomized crossover trial comparing continuous and cyclic stimulation in InterStim therapy. Female Pelvic Med Reconstr Surg. 2015;21:355–358. doi:10.1097/SPV.000000000000018826506165
   PubMed Web of Science ®Google Scholar
• Groen J, Blok BF, Bosch JL. Sacral neuromodulation as treatment for refractory idiopathic urge urinary incontinence: 5-year results of a longitudinal study in 60 women. J Urol. 2011;186:954–959. doi:10.1016/j.juro.2011.04.05921791355
   PubMed Web of Science ®Google Scholar
• Mehmood S, Altaweel WM. Long-term outcome of sacral neuromodulation in patients with idiopathic nonobstructive urinary retention: single-center experience. Urol Ann. 2017;9:244–248. doi:10.4103/UA.UA_165_1628794590
   PubMed Web of Science ®Google Scholar
• Amundsen CL, Komesu YM, Chermansky C, et al. Two-year outcomes of sacral neuromodulation versus onabotulinumtoxinA for refractory urgency urinary incontinence: a randomized trial. Eur Urol. 2018;74:66–73. doi:10.1016/j.eururo.2018.02.01129482936
   PubMed Web of Science ®Google Scholar
• Amundsen CL, Richter HE, Menefee SA, et al. OnabotulinumtoxinA vs sacral neuromodulation on refractory urgency urinary incontinence in women: a randomized clinical trial. JAMA. 2016;316:1366–1374. doi:10.1001/jama.2016.1461727701661
   PubMed Web of Science ®Google Scholar
• Blok BF. OnabotulinumtoxinA vs sacral neuromodulation for urgency incontinence. JAMA. 2017;317:534–535. doi:10.1001/jama.2016.1956028170473
   PubMed Web of Science ®Google Scholar
• The Axonics r-SNM System, 2019. Available from: http://www.axonicsmodulation.com/product/. Accessed 1212, 2018.
   Google Scholar
• Blok BF, Van Kerrebroeck P, de Wachter S, et al. Programming settings and recharge interval in a prospective study of a rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourol Urodyn. 2018;37:S17–S22. doi:10.1002/nau.2347629336058
   PubMed Web of Science ®Google Scholar
• Noblett KL, Dmochowski RR, Vasavada SP, et al. Cost profiles and budget impact of rechargeable versus non-rechargeable sacral neuromodulation devices in the treatment of overactive bladder syndrome. Neurourol Urodyn. 2017;36:727–733. doi:10.1002/nau.2300827062384
   PubMed Web of Science ®Google Scholar
• Blok BF, Van Kerrebroeck P, de Wachter S, et al. Three month clinical results with a rechargeable sacral neuromodulation system for the treatment of overactive bladder. Neurourol Urodyn. 2018;37:S9–S16. doi:10.1002/nau.2346529315785
   PubMed Web of Science ®Google Scholar
• Blok BF, Van Kerrebroeck P, de Wachter S, et al. A prospective, multicenter study of a novel, miniaturized rechargeable sacral neuromodulation system: 12-month results from the RELAX-OAB study. Neurourol Urodyn. 2019;38:689–695. doi:10.1002/nau.2389230592526
   PubMed Web of Science ®Google Scholar
• Ramirez-Garcia I, Blanco-Ratto L, Kauffmann S, et al. Efficacy of transcutaneous stimulation of the posterior tibial nerve compared to percutaneous stimulation in idiopathic overactive bladder syndrome: randomized control trial. Neurourol Urodyn. 2018;38:261–268. doi:10.1002/nau.2384330311692
   PubMed Web of Science ®Google Scholar
• Physicians, Overactive Bladder, 2018. Available from: http://www.bluewindmedical.com/bluewind-renova. Accessed 216, 2019
   Google Scholar
• Heesakkers JPFA, Digesu GA, van Breda J, et al. A novel leadless, miniature implantable tibial nerve neuromodulation system for the management of overactive bladder complaints. Neurourol Urodyn. 2018;37:1060–1067. doi:10.1002/nau.2340128892221
   PubMed Web of Science ®Google Scholar
• MacDiarmid S, Staskin DR, Lucente V, et al. Feasibility of a fully implanted, nickel sized and shaped tibial nerve stimulator for the treatment of overactive bladder syndrome with urgency urinary incontinence. J Urol. 2019;201(5):967–972. doi:10.1016/j.juro.2018.10.01731009968
   PubMed Web of Science ®Google Scholar
• Yune JJ, Shen JK, Pierce MA, et al. Intravesical electrical stimulation treatment for overactive bladder: an observational study. Investig Clin Urol. 2018;59:246–251.
   Web of Science ®Google Scholar
• Deng H, Liao L, Wu J, et al. Clinical efficacy of intravesical electrical stimulation on detrusor underactivity: 8 years of experience from a single center. Medicine (Baltimore). 2017;96:e8020. doi:10.1097/MD.000000000000802028930838
   PubMed Web of Science ®Google Scholar
• Hokanson JA, Langdale CL, Sridhar A, et al. Stimulation of the sensory pudendal nerve increases bladder capacity in the rat. Am J Physiol Renal Physiol. 2018;314:F543–F550. doi:10.1152/ajprenal.00373.201729141938
   PubMed Web of Science ®Google Scholar
• Jiang HH, Song QX, Gill BC, et al. Electrical stimulation of the pudendal nerve promotes neuroregeneration and functional recovery from stress urinary incontinence in a rat model. Am J Physiol Renal Physiol. 2018;315:1555–1564. doi:10.1152/ajprenal.00431.2017
   Web of Science ®Google Scholar
• Peters KM, Feber KM, Bennett RC. Sacral versus pudendal nerve stimulation for voiding dysfunction: a prospective, single-blinded, randomized, crossover trial. Neurourol Urodyn. 2005;24:643–647. doi:10.1002/nau.2017416178000
   PubMed Web of Science ®Google Scholar
• Sharan E, Hunter K, Hassouna M, et al. Characterizing the transcutaneous electrical recruitment of lower leg afferents in healthy adults: implications for non-invasive treatment of overactive bladder. BMC Urol. 2018;18:10. doi:10.1186/s12894-018-0322-y.29523118
   PubMed Web of Science ®Google Scholar
• MacDiarmid SA, John MS, Yoo PB. A pilot feasibility study of treating overactive bladder patients with percutaneous saphenous nerve stimulation. Neurourol Urodyn. 2018;37:1815–1820. doi:10.1002/nau.2353129464764
   PubMed Web of Science ®Google Scholar
• Slovak M, Chapple CR, Barker AT. Non-invasive transcutaneous electrical stimulation in the treatment of overactive bladder. Asian J Urol. 2015;2:92–101. doi:10.1016/j.ajur.2015.04.01329264126
   PubMed Web of Science ®Google Scholar
• Wollner J, Krebs J, Pannek J. Sacral neuromodulation in patients with neurogenic lower urinary tract dysfunction. Spinal Cord. 2016;54:137–140. doi:10.1038/sc.2015.12426215913
   PubMed Web of Science ®Google Scholar
• Ren J, Chew DJ, Biers S, et al. Electrical nerve stimulation to promote micturition in spinal cord injury patients: a review of current attempts. Neurourol Urodyn. 2016;35:365–370. doi:10.1002/nau.2273025663151
   PubMed Web of Science ®Google Scholar
• Engeler DS, Meyer D, Abt D, et al. Sacral neuromodulation for the treatment of neurogenic lower urinary tract dysfunction caused by multiple sclerosis: a single-centre prospective series. BMC Urol. 2015;15:105.25887442
   PubMed Web of Science ®Google Scholar
• Bladder Stimulator Leaflet, 2018. Available from: https://finetech-medical.co.uk/products/finetech-brindley-bladder-control-system/.Accessed 1215, 2018.
   Google Scholar
• Vastenholt JM, Snoek GJ, Buschman HP, et al. A 7-year follow-up of sacral anterior root stimulation for bladder control in patients with a spinal cord injury: quality of life and users’ experiences. Spinal Cord. 2003;41:397–402. doi:10.1038/sj.sc.310146512815371
   PubMed Web of Science ®Google Scholar
• Li LF, Ka-Kit Leung G, Lui WM. Sacral nerve stimulation for neurogenic bladder. World Neurosurg. 2016;90:236–243. doi:10.1016/j.wneu.2016.02.10826960284
   PubMed Web of Science ®Google Scholar
• Li T, Feng X, Lv J, Cai T, Wang S. Short-term Clinical efficacy of electric pudendal nerve stimulation on neurogenic lower urinary tract disease: a pilot research. Urology. 2018;112:69–73. doi:10.1016/j.urology.2017.10.04729175451
   PubMed Web of Science ®Google Scholar
• Schneider MP, Gross T, Bachmann LM, et al. Tibial nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review. Eur Urol. 2015;68:859–867. doi:10.1016/j.eururo.2015.07.00126194043
   PubMed Web of Science ®Google Scholar
• Canbaz Kabay S, Kabay S, Mestan E, et al. Long term sustained therapeutic effects of percutaneous posterior tibial nerve stimulation treatment of neurogenic overactive bladder in multiple sclerosis patients: 12-months results. Neurourol Urodyn. 2017;36:104–110. doi:10.1002/nau.2286826352904
   PubMed Web of Science ®Google Scholar
• Kabay S, Canbaz Kabay S, Cetiner M, et al. The clinical and urodynamic results of percutaneous posterior tibial nerve stimulation on neurogenic detrusor overactivity in patients with Parkinson’s disease. Urology. 2016;87:76–81. doi:10.1016/j.urology.2015.09.02626436213
   PubMed Web of Science ®Google Scholar
• Gross T, Schneider MP, Bachmann LM, et al. Transcutaneous electrical nerve stimulation for treating neurogenic lower urinary tract dysfunction: a systematic review. Eur Urol. 2016;69:1102–1111. doi:10.1016/j.eururo.2016.01.01026831506
   PubMed Web of Science ®Google Scholar
• Guo ZF, Liu Y, Hu GH, et al. Transcutaneous electrical nerve stimulation in the treatment of patients with poststroke urinary incontinence. Clin Interv Aging. 2014;9:851–856. doi:10.2147/CIA.S6108424904204
   PubMed Web of Science ®Google Scholar
• Brusa L, Finazzi Agro E, Petta F, et al. Effects of inhibitory rTMS on bladder function in Parkinson’s disease patients. Mov Disord. 2009;24(3):445–448. doi:10.1002/mds.2243419133657
   PubMed Web of Science ®Google Scholar
• Centonze D, Petta F, Versace V, et al. Effects of motor cortex rTMS on lower urinary tract dysfunction in multiple sclerosis. Mult Scler. 2007;13(2):269–271. doi:10.1177/135245850607072917439897
   PubMed Web of Science ®Google Scholar
• Vasquez N, Balasubramaniam V, Kuppuswamy A, et al. The interaction of cortico-spinal pathways and sacral sphincter reflexes in subjects with incomplete spinal cord injury: a pilot study. Neurourol Urodyn. 2015;34(4):349–355. doi:10.1002/nau.2255425867009
   PubMed Web of Science ®Google Scholar